Recruitment

Recruitment Status
Completed
Estimated Enrollment
4000

Summary

Conditions
Venous Thromboembolic Diseases
Type
Interventional
Phase
Not Applicable
Design
Allocation: RandomizedIntervention Model: Factorial AssignmentMasking: None (Open Label)Primary Purpose: Prevention

Participation Requirements

Age
Between 15 years and 48 years
Gender
Only males

Description

Venous thromboembolism (VTE) is the leading cause of maternal mortality and morbidity in the developed and developing world. Pulmonary embolism and deep vein thrombosis are the two components of a single disease called deep vein thrombosis (DVT). Pregnancy associated with an average 5 to 10 fold inc...

Venous thromboembolism (VTE) is the leading cause of maternal mortality and morbidity in the developed and developing world. Pulmonary embolism and deep vein thrombosis are the two components of a single disease called deep vein thrombosis (DVT). Pregnancy associated with an average 5 to 10 fold increase in the risk of VTE compared with non-pregnant women. The highest incidence occurring during the post partum period. There are many researches done a broad on the effect of LMWH to decrease the incidence of VTE after Caesarean section using the two LMWH (Enoxaparin and Bemiparin) alone but not in one research comparing both of them alone and both together against a control group. Also according to our knowledge there are no published literature on thromboprophylaxis after vaginal delivery

Tracking Information

NCT #
NCT01588171
Collaborators
Not Provided
Investigators
Principal Investigator: Shahla K. Alalaf, Ass.Prof Hawler Medical University Study Chair: Rojan K. Jawad, High Diploma Hawler Medical University Study Chair: Parez R. Muhammad, High Diploma Hawler Medical University Study Chair: Mahabad S. Ali, High Diploma Hawler ministry of Health, Directorate of Health Study Director: Namir G. Al Tawil, Professor Hawler Medical University